Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Med Decis Making. 2022 Jun 30;43(1):3–20. doi: 10.1177/0272989X221103163

Table 2:

Description of parameters, their R variable name, base-case values and distribution.

Parameter R name Base-case Distribution
Number of cycles (nT) n_cycles 75 years -
Names of health states (n) v_names_states H, S1, S2, D -
Annual discount rate for costs d_c 3% -
Annual discount rate for QALYs d_e 3% -
Number of PSA samples (K) n_sim 1,000 -
Annual constant transition rates
- Disease onset (H to S1) r_HS1 0.150 gamma(30, 200)
- Recovery (S1 to H) r_S1H 0.500 gamma(60, 120)
- Disease progression (S1 to S2) r_S1S2 0.105 gamma(84, 800)
Annual mortality
- Background mortality rate (H to D) r_HD 0.002 gamma(20, 10000)
- Hazard ratio of death in S1 vs H hr_S1 3.0 lognormal(log(3.0), 0.01)
- Hazard ratio of death in S2 vs H hr_S2 10.0 lognormal(log(10.0), 0.02)
Annual costs
- Healthy individuals c_H $2,000 gamma(100.0, 20.0)
- Sick individuals in S1 c_S1 $4,000 gamma(177.8, 22.5)
- Sick individuals in S2 c_S2 $15,000 gamma(225.0, 66.7)
- Dead individuals c_D $0 -
Utility weights
- Healthy individuals u_H 1.00 beta(200, 3)
- Sick individuals in S1 u_S1 0.75 beta(130, 45)
- Sick individuals in S2 u_S2 0.50 beta(230, 230)
- Dead individuals u_D 0.00 -
Treatment A cost and effectiveness
- Cost of treatment A, additional to state-specific health care costs c_trtA $12,000 gamma(73.5, 163.3)
- Utility for treated individuals in S1 u_trtA 0.95 beta(300, 15)
Treatment B cost and effectiveness
- Cost of treatment B, additional to state-specific health care costs c_trtB $12,000 gamma(86.2, 150.8)
- Reduction in rate of disease progression (S1 to S2) as hazard ratio (HR) hr_S1S2_trtB log(0.6) lognormal(log(0.6), 0.02)